Nicholas M. Burke
Plus aucun poste en cours
Profil
Nicholas M.
Burke served as Vice President of Financial Operations for Bioheart, Inc. from July 2007 to January 16, 2009.
From October 2001 to June 2007, he served as Vice President and Controller of Viragen, Inc. Prior to joining Viragen, Mr. Burke was Controller of SmartDisk Corporation from October 1999 to October 2001.
From September 1994 to September 1999, he was a Senior Member of the Audit Staff of Ernst & Young LLP.
Mr. Burke received a Master's degree in Accounting from Florida International University in 1996 and a Bachelors degree in Accounting from Florida International University in 1993.
Anciens postes connus de Nicholas M. Burke
| Sociétés | Poste | Fin |
|---|---|---|
| U.S. STEM CELL, INC. | Corporate Officer/Principal | 16/01/2009 |
Viragen International, Inc.
 Viragen International, Inc. BiotechnologyHealth Technology The Group's principal activities are to research, develop, manufacture and market a natural human alpha interferon product indicated for treatment of a broad range of viral and malignant diseases. The Group produces a natural human alpha interferon product under the tradename of MultiferonTMfrom human white blood cells, also known as leukocytes. Natural interferon-alpha is one of the body's most important natural defense mechanisms to foreign substances like viruses, but it also stimulates and modulates the human immune system. In addition, interferon inhibits the growth of various viruses including those associated with diseases like hepatitis, some types of cancer, multiple sclerosis, and severe acute respiratory syndrome (SARS). | Comptroller/Controller/Auditor | 06/07/2007 |
Viragen, Inc.
 Viragen, Inc. BiotechnologyHealth Technology Viragen, Inc. is a biotechnology company specializing in the research, development and commercialization of natural and recombinant protein-based drugs designed to treat a broad range of viral and malignant diseases. These protein-based drugs include natural human alpha interferon and monoclonal antibodies. Viragen's strategy also includes the development of Avian Transgenic Technology as a biomanufacturing platform for the large-scale, cost-effective production of therapeutic proteins. The firm is located in Plantation, FL. | Comptroller/Controller/Auditor | 01/06/2007 |
| SMARTDISK CORPORATION | Comptroller/Controller/Auditor | 01/10/2001 |
Formation de Nicholas M. Burke
| Florida International University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| U.S. STEM CELL, INC. | Health Services |
| Entreprise privées | 3 |
|---|---|
Viragen, Inc.
Viragen, Inc. BiotechnologyHealth Technology Viragen, Inc. is a biotechnology company specializing in the research, development and commercialization of natural and recombinant protein-based drugs designed to treat a broad range of viral and malignant diseases. These protein-based drugs include natural human alpha interferon and monoclonal antibodies. Viragen's strategy also includes the development of Avian Transgenic Technology as a biomanufacturing platform for the large-scale, cost-effective production of therapeutic proteins. The firm is located in Plantation, FL. | Health Technology |
Viragen International, Inc.
Viragen International, Inc. BiotechnologyHealth Technology The Group's principal activities are to research, develop, manufacture and market a natural human alpha interferon product indicated for treatment of a broad range of viral and malignant diseases. The Group produces a natural human alpha interferon product under the tradename of MultiferonTMfrom human white blood cells, also known as leukocytes. Natural interferon-alpha is one of the body's most important natural defense mechanisms to foreign substances like viruses, but it also stimulates and modulates the human immune system. In addition, interferon inhibits the growth of various viruses including those associated with diseases like hepatitis, some types of cancer, multiple sclerosis, and severe acute respiratory syndrome (SARS). | Health Technology |
SmartDisk Corp.
 SmartDisk Corp. Computer PeripheralsElectronic Technology SmartDisk Corp. provides portable, network and multimedia storage products and technologies that enable people to enjoy, share and preserve digital content and information. The company's products help users to transfer, store, manage & share digital music, video, pictures, and data. The company was founded in March 1997 and is headquartered in Fort Myers, FL. | Electronic Technology |